1. Home
  2. MATW vs DSGN Comparison

MATW vs DSGN Comparison

Compare MATW & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$28.69

Market Cap

781.0M

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$13.33

Market Cap

819.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
DSGN
Founded
1850
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
781.0M
819.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
MATW
DSGN
Price
$28.69
$13.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$15.25
AVG Volume (30 Days)
125.7K
469.9K
Earning Date
04-30-2026
04-28-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
N/A
EPS
1.39
N/A
Revenue
$1,795,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.62
$3.11
52 Week High
$29.11
$17.25

Technical Indicators

Market Signals
Indicator
MATW
DSGN
Relative Strength Index (RSI) 65.44 55.22
Support Level $25.38 $9.71
Resistance Level $29.11 $13.54
Average True Range (ATR) 0.83 1.07
MACD 0.10 0.02
Stochastic Oscillator 48.02 25.42

Price Performance

Historical Comparison
MATW
DSGN

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Share on Social Networks: